1,262 press releases indexed under retail.
Text's full suite of products and new AI agents now integrate with all of the tools and platforms where e-commerce happens – including Shopify, WhatsApp for Business, Meta Business, WordPress, and WebFlow BOSTON and WROCLAW, Poland, July 1, 2026 /PRNewswire-PRWeb/ -- Text, an AI-powered...
Advance America Meets Customers Where They Are with App in ChatGPT GREENVILLE, S.C., July 1, 2026 /PRNewswire/ -- Advance America, a nationally recognized consumer lender serving customers since 1997, announced the availability of the Advance America app in ChatGPT. The app brings branch...
Research Highlights: GLP-1RA (glucagon-like peptide-1 receptor agonist) medications, which are prescribed to treat Type 2 diabetes and to help with weight loss, were found to reduce the number of deaths, amputations and hospitalizations among people with Type 2 diabetes and narrowed leg arteries associated with PAD (peripheral artery disease). People who had severely blocked arteries in their legs and those with obesity were most likely to benefit from taking a GLP-1RA. In addition, people taking GLP1-RAs needed fewer procedures to restore blood flow to their legs. DALLAS - July 1, 2026 ( NEWMEDIAWIRE ) - GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations among people with Type 2 diabetes who also had narrowed leg arte
Benetton Group has strengthened its digital strategy with the successful migration of the benetton.com and sisley.com e-commerce websites to the Shopify platform. The move marks the transition to a more agile and scalable technology architecture that enables faster responses to changes in the global market. - - The initiative is part of CEO Claudio Sforza 's strategic plan, aimed at enhancing the e-commerce channel and aligning the Group with industry best benchmarks. The project follow... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=356974
Acquisition strengthens local manufacturing and logistics capabilities as REJURAN Cosmetics expands across Sephora, Amazon and Canada, with future growth across the Americas in view SEOUL, South Korea, July 1, 2026 /PRNewswire/ -- PharmaResearch, the South Korea-based regenerative...
As companies navigate economic uncertainty, digital disruption, and rapidly shifting consumer expectations, Jose Daniel Duarte Camacho is emphasizing business agility as a critical factor for sustainable growth, operational resilience, and long-term competitiveness. - - Business agility has moved beyond a management trend and has become a core business requirement. Organizations are under pressure to respond faster to market changes, improve customer experience, reduce operational frictio... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=356971
TORONTO, June 30, 2026 /PRNewswire/ - Reklaim Ltd. (TSXV: MYID) (OTC: MYIDF) ("Reklaim" or the "Company"), a consumer privacy and data company that enables individuals to view, control, remove and monetize their personal data while providing brands with consent-based audience data,...
LOS ANGELES, CA - June 30, 2026 ( NEWMEDIAWIRE ) - SS Innovations International (NASDAQ: SSII) announced it has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, which recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. The company said the award reflects growing adoption of its SSi Mantra surgical robotic system, which it believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency. As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The c
LOS ANGELES, CA - June 30, 2026 ( NEWMEDIAWIRE ) - HeartBeam (NASDAQ: BEAT) announced it has completed patient enrollment ahead of schedule in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection. The study enrolled 120 patients presenting with chest pain at two clinical sites in Belgrade, Serbia, with participants evaluated using both a standard 12-lead ECG and the company’s 3D ECG technology. Data analysis is underway, and HeartBeam plans to present the results at a major cardiology conference later this year. The company said the study results are expected to support discussions with the FDA on the design of a planned U.S. pivotal trial and a future submission to expand the HeartBeam System’s indication beyond arrhythmia assessment to include heart attack
LOS ANGELES, CA - June 30, 2026 ( NEWMEDIAWIRE ) - When most people think about their risk for heart disease, they think about family history. Did a parent or grandparent have a heart attack? Is heart disease “in their genes”? It’s an understandable assumption, and genetics does play a role in cardiovascular risk. But a growing body of research suggests that DNA sequence alone tells only part of the story, and increasingly, scientists believe it may be the smaller part. The rest of the story is largely written in epigenetics, a field of biology that examines how genes are switched on or off, turned up or down, without any change to the underlying DNA code itself. Cardio Diagnostics Holdings (NASDAQ: CDIO) , a medical technology company built around epigenetics-based cardiovascular testing,